Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
462 First Ave.
BCD 556
New York, NY 10016Phone+1 212-263-6485Fax+1 212-263-8210
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Obstetrics and Gynecology, 2000 - 2004
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2000 - 2003- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2000 - 2001
Albert Einstein College of MedicineClass of 2000
Medical University of South CarolinaClass of 2000
Certifications & Licensure
NY State Medical License 2001 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer Start of enrollment: 2014 Dec 01
Publications & Presentations
PubMed
- 14 citationsHepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysisHolly Hagan, Joshua Neurer, Ashly E. Jordan, Don C. Des Jarlais, Jennifer Wu
Systematic Reviews. 2014-03-26 - 79 citationsCD73: an emerging checkpoint for cancer immunotherapy.Siqi Chen, Derek A. Wainwright, Jennifer D. Wu, Yong Wan, Daniela Matei
Immunotherapy. 2019-06-21 - 1226 citationsTumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activationVeronika Groh, Jennifer D. Wu, Cassian Yee, Thomas Spies
Nature. 2002-10-17
Press Mentions
Intermittent Androgen Deprivation with the GnRH Antagonist Degarelix in Men with Biochemical Relapse of Prostate CancerJanuary 3rd, 2016- Immunotherapy Not Ready for Prime Time in Ovarian CancerNovember 5th, 2015
- Neoadjuvant Chemo Use Rises in Ovarian Cancer, Despite Unclear Survival DataNovember 5th, 2015
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
